Abstract
Over the last decade, considerable progress has been made in gastrointestinal stromal tumor (GIST) with respect to determining prognosis and therapy. Here, we will summarize some of the major developments and how they have led to an increased use of personalized treatment in GIST.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Benzamides
-
Gastrointestinal Stromal Tumors / drug therapy
-
Gastrointestinal Stromal Tumors / genetics*
-
Gastrointestinal Stromal Tumors / secondary
-
Humans
-
Imatinib Mesylate
-
Piperazines / therapeutic use
-
Precision Medicine*
-
Prognosis
-
Protein Kinase Inhibitors / therapeutic use
-
Pyrimidines / therapeutic use
Substances
-
Benzamides
-
Piperazines
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Imatinib Mesylate